Prostate cancer genomics, biology, and risk assessment through genome-wide association studies

Hidewaki Nakagawa, Shusuke Akamatsu, Ryo Takata, Atsushi Takahashi, Michiaki Kubo, Yusuke Nakamura

Research output: Contribution to journalReview article

19 Citations (Scopus)

Abstract

Prostate cancer (PC) is the most common malignancy observed in men. It is evident that genetic factors play some important roles in PC etiology. Recently, genome-wide association studies in diverse ethnic groups have identified more than 40 germline variants of various genes or chromosomal loci that are significantly associated with PC susceptibility, including multiple 8q24 loci, prostate-specific genes, metabolic and hormone-related genes, and many regions where no coding gene is annotated. However, there are only a few variants or genes for which biological significance or functions have been elucidated so far. The greatest challenge related to genome-wide association studies loci in prostate genomics is to understand the functional consequences of these PC-associated loci and their involvement in PC biology and carcinogenesis. There have been attempts to determine PC risk estimations by combining multiple PC-associated variants for clinical tests, and these can identify a very minor population with high risk of PC. However, they cannot distinguish risk of aggressive PC from that of non-aggressive PC. Further identification of PC-susceptibility loci in larger genome-wide association studies cohorts and biological insights gained from such functional analyses have the potential to translate into clinical benefits, including the development of reliable biomarkers, risk estimation, and effective strategies for screening and prevention of PC.

Original languageEnglish
Pages (from-to)607-613
Number of pages7
JournalCancer Science
Volume103
Issue number4
DOIs
Publication statusPublished - 01-04-2012

Fingerprint

Genome-Wide Association Study
Genomics
Prostatic Neoplasms
Genes
Prostate
Ethnic Groups
Carcinogenesis
Biomarkers
Hormones

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nakagawa, Hidewaki ; Akamatsu, Shusuke ; Takata, Ryo ; Takahashi, Atsushi ; Kubo, Michiaki ; Nakamura, Yusuke. / Prostate cancer genomics, biology, and risk assessment through genome-wide association studies. In: Cancer Science. 2012 ; Vol. 103, No. 4. pp. 607-613.
@article{41736522242f418aa1fedb024b25ff4e,
title = "Prostate cancer genomics, biology, and risk assessment through genome-wide association studies",
abstract = "Prostate cancer (PC) is the most common malignancy observed in men. It is evident that genetic factors play some important roles in PC etiology. Recently, genome-wide association studies in diverse ethnic groups have identified more than 40 germline variants of various genes or chromosomal loci that are significantly associated with PC susceptibility, including multiple 8q24 loci, prostate-specific genes, metabolic and hormone-related genes, and many regions where no coding gene is annotated. However, there are only a few variants or genes for which biological significance or functions have been elucidated so far. The greatest challenge related to genome-wide association studies loci in prostate genomics is to understand the functional consequences of these PC-associated loci and their involvement in PC biology and carcinogenesis. There have been attempts to determine PC risk estimations by combining multiple PC-associated variants for clinical tests, and these can identify a very minor population with high risk of PC. However, they cannot distinguish risk of aggressive PC from that of non-aggressive PC. Further identification of PC-susceptibility loci in larger genome-wide association studies cohorts and biological insights gained from such functional analyses have the potential to translate into clinical benefits, including the development of reliable biomarkers, risk estimation, and effective strategies for screening and prevention of PC.",
author = "Hidewaki Nakagawa and Shusuke Akamatsu and Ryo Takata and Atsushi Takahashi and Michiaki Kubo and Yusuke Nakamura",
year = "2012",
month = "4",
day = "1",
doi = "10.1111/j.1349-7006.2011.02193.x",
language = "English",
volume = "103",
pages = "607--613",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "4",

}

Prostate cancer genomics, biology, and risk assessment through genome-wide association studies. / Nakagawa, Hidewaki; Akamatsu, Shusuke; Takata, Ryo; Takahashi, Atsushi; Kubo, Michiaki; Nakamura, Yusuke.

In: Cancer Science, Vol. 103, No. 4, 01.04.2012, p. 607-613.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Prostate cancer genomics, biology, and risk assessment through genome-wide association studies

AU - Nakagawa, Hidewaki

AU - Akamatsu, Shusuke

AU - Takata, Ryo

AU - Takahashi, Atsushi

AU - Kubo, Michiaki

AU - Nakamura, Yusuke

PY - 2012/4/1

Y1 - 2012/4/1

N2 - Prostate cancer (PC) is the most common malignancy observed in men. It is evident that genetic factors play some important roles in PC etiology. Recently, genome-wide association studies in diverse ethnic groups have identified more than 40 germline variants of various genes or chromosomal loci that are significantly associated with PC susceptibility, including multiple 8q24 loci, prostate-specific genes, metabolic and hormone-related genes, and many regions where no coding gene is annotated. However, there are only a few variants or genes for which biological significance or functions have been elucidated so far. The greatest challenge related to genome-wide association studies loci in prostate genomics is to understand the functional consequences of these PC-associated loci and their involvement in PC biology and carcinogenesis. There have been attempts to determine PC risk estimations by combining multiple PC-associated variants for clinical tests, and these can identify a very minor population with high risk of PC. However, they cannot distinguish risk of aggressive PC from that of non-aggressive PC. Further identification of PC-susceptibility loci in larger genome-wide association studies cohorts and biological insights gained from such functional analyses have the potential to translate into clinical benefits, including the development of reliable biomarkers, risk estimation, and effective strategies for screening and prevention of PC.

AB - Prostate cancer (PC) is the most common malignancy observed in men. It is evident that genetic factors play some important roles in PC etiology. Recently, genome-wide association studies in diverse ethnic groups have identified more than 40 germline variants of various genes or chromosomal loci that are significantly associated with PC susceptibility, including multiple 8q24 loci, prostate-specific genes, metabolic and hormone-related genes, and many regions where no coding gene is annotated. However, there are only a few variants or genes for which biological significance or functions have been elucidated so far. The greatest challenge related to genome-wide association studies loci in prostate genomics is to understand the functional consequences of these PC-associated loci and their involvement in PC biology and carcinogenesis. There have been attempts to determine PC risk estimations by combining multiple PC-associated variants for clinical tests, and these can identify a very minor population with high risk of PC. However, they cannot distinguish risk of aggressive PC from that of non-aggressive PC. Further identification of PC-susceptibility loci in larger genome-wide association studies cohorts and biological insights gained from such functional analyses have the potential to translate into clinical benefits, including the development of reliable biomarkers, risk estimation, and effective strategies for screening and prevention of PC.

UR - http://www.scopus.com/inward/record.url?scp=84859005156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859005156&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2011.02193.x

DO - 10.1111/j.1349-7006.2011.02193.x

M3 - Review article

C2 - 22181854

AN - SCOPUS:84859005156

VL - 103

SP - 607

EP - 613

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 4

ER -